Grifols Financial Statements From 2010 to 2024
| GRF Stock | EUR 9.69 0.97 9.10% |
Check Grifols SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Grifols SA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Grifols financial statements analysis is a perfect complement when working with Grifols SA Valuation or Volatility modules.
Grifols |
Grifols SA Company Profit Margin Analysis
Grifols SA's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Grifols SA Profit Margin | 0.01 % |
Most of Grifols SA's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Grifols SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Grifols SA has a Profit Margin of 0.0115%. This is 100.1% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The profit margin for all Spain stocks is 100.91% lower than that of the firm.
Grifols SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Grifols SA's current stock value. Our valuation model uses many indicators to compare Grifols SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Grifols SA competition to find correlations between indicators driving Grifols SA's intrinsic value. More Info.Grifols SA is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.85 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Grifols SA is roughly 1.17 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Grifols SA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Grifols SA's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Grifols SA Financial Statements
Grifols SA stakeholders use historical fundamental indicators, such as Grifols SA's revenue or net income, to determine how well the company is positioned to perform in the future. Although Grifols SA investors may analyze each financial statement separately, they are all interrelated. For example, changes in Grifols SA's assets and liabilities are reflected in the revenues and expenses on Grifols SA's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Grifols SA. Please read more on our technical analysis and fundamental analysis pages.
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. GRIFOLS S operates under Drug ManufacturersGeneral classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 24000 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Grifols Stock
Grifols SA financial ratios help investors to determine whether Grifols Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Grifols with respect to the benefits of owning Grifols SA security.